From: Is there any role of intravenous iron for the treatment of anemia in cancer?
 | Patients | Percent |
---|---|---|
Chemotherapy combinations | ||
 Docetaxel + Cisplatin (±5FU) | 15 | 23.8 % |
 FOLFOX | 12 | 19 % |
 FEC | 10 | 15.8 % |
 Paclitaxel + Carboplatin | 7 | 11.1 % |
 Capecitabine | 5 | 8 % |
 FUFA | 2 | 3.1 % |
 Others | 12 | 19.2 % |
Radiotherapy areas | ||
 Bony areas | 15 | 23.8 % |
 Pelvic region | 10 | 15.8 % |
 Thoracic region | 7 | 11.1 % |
 Upper abdomen | 4 | 6.3 % |
 Brain | 1 | 1.5 % |